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Edited by Judit Ova´diAbstract Glycogenin acts in the initiation step of glycogen bio-
synthesis by catalyzing a self-glucosylation reaction. In a previ-
ous work [de Paula et al., Arch. Biochem. Biophys. 435 (2005)
112–124], we described the isolation of the cDNA gnn, which en-
codes the protein glycogenin (GNN) in Neurospora crassa. This
work presents a set of biochemical and functional studies conﬁrm-
ing the GNN role in glycogen biosynthesis. Kinetic experiments
showed a very low GNN Km (4.41 lM) for the substrate UDP-
glucose. Recombinant GNN was produced in Escherichia coli
and analysis by mass spectroscopy identiﬁed a peptide containing
an oligosaccharide chain attached to Tyr196 residue. Site-direc-
ted mutagenesis and functional complementation of a Saccharo-
myces cerevisiae mutant strain conﬁrmed the participation of
this residue in the GNN self-glucosylation and indicated the
Tyr198 residue as an additional, although less active, glucosyla-
tion site. The physical interaction between GNN and glycogen
synthase (GSN) was analyzed by the two-hybrid assay. While
the entire GSN was required for full interaction, the C-terminus
in GNN was more important. Furthermore, mutation in the GNN
glucosylation sites did not impair the interaction with GSN.
 2005 Published by Elsevier B.V. on behalf of the Federation of
European Biochemical Societies.
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Glycogen, a polymer of glucose, is one of the most impor-
tant storage carbohydrates in a wide range of species. Its bio-
synthesis involves three enzymes: glycogen synthase (ECAbbreviations: DTT, dithiothreitol; GAPD, glyceraldehyde-3-phos-
phate dehydrogenase; GNIP, glycogenin-interacting protein; GS,
glycogen synthase; GST, glutathione-S-transferase; HEPES, N-(2-
hydroxyethyl) piperazine-N0-(2-ethanesulfonic acid); MW, molecular
weight; PAGE, polyacrylamide gel electrophoresis; PBS, phosphate
buﬀered saline; PCR, polymerase chain reaction; PMSF, phenylmeth-
ylsulfonyl ﬂuoride; SDS, sodium dodecyl sulfate; TLCK, N-p-tosyl-L-
lysine choromethyl ketone; UDPG, uridine diphosphoglucose; VM,
Vogel minimum; WT, wild type
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doi:10.1016/j.febslet.2005.02.0752.4.1.11), branching enzyme (EC 2.4.1.18), and glycogenin
(EC 2.4.1.186), a self-glucosylating protein, which acts in the
ﬁrst step of glycogen biogenesis [1]. Glycogenin has the ability
to self-glucosylate, via a 1-O-tyrosyl linkage [2], and to poly-
merize an oligosaccharide up to 10 residues [3]. Once glucosy-
lated, glycogenin acts as the substrate for elongation by
glycogen synthase [4], which catalyses the formation of a-1,4-
glycosidic bonds. Both enzymes require the sugar-nucleotide
UDP-glucose as substrate. The bulk synthesis of glycogen is
completed by the action of the branching enzyme, which intro-
duces branch points, through the formation of a-1,6-glycosidic
bonds [5].
The mechanisms that control glycogen synthesis have been
extensively studied and most knowledge has come from studies
of mammals and the yeast Saccharomyces cerevisiae. Rabbit
skeletal muscle glycogenin is self-glucosylated at residue
Tyr194, and mutation of this residue led to a protein unable
to attach glucoses to itself [6]. In the yeast S. cerevisiae, there
are two genes, GLG1 and GLG2 encoding glycogenin like-pro-
teins Glg1p and Glg2p [7]. In contrast to mammalian glycog-
enin, Glg proteins possess multiple tyrosine residues involved
in self-glucosylation and mutation in all are necessary to inac-
tivate the self-glucosylation, and therefore, for complete aboli-
tion of glycogen accumulation [8].
The three-dimensional structure for rabbit skeletal muscle
glycogenin, recently solved to 1.9 A˚, has provided insights into
the catalytic mechanism of this enzyme [9]. The overall fold is
very similar to structures of the glycosyltransferase family pro-
teins to which glycogenin belongs. Glycogenin behaves as a di-
mer in solution [10], and can exist as a pentamer of dimers in
the crystals, although the biological relevance of the decamer is
uncertain. The dimeric form may be important for function
since some mutational studies support a model in which one
subunit of a dimer transfers glucose to its partner in an inter-
subunit reaction [11]. However, the structure proposed by Gib-
bons et al. [9] does not fully explain the mechanistic properties
of the reaction. Besides its ability to self-glucosylate, glycoge-
nin can also transfer glucose residues to small molecule accep-
tors, in a trans-glucosylation reaction [12] although there is no
evidence to support the physiological relevance of this activity.
Both self- and trans-glucosylation activities are strongly en-
hanced by the presence of Mn2+ ions [4].
In previous work, we described the isolation and character-
ization of a cDNA derived from the gnn gene, which encodes aation of European Biochemical Societies.
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rospora crassa [13]. Expression of GNN in Escherichia coli cells
resulted in a protein that was very susceptible to proteolysis
leading to lower MW species that retained most glycogenin-re-
lated activities, such as self- and trans-glucosylation activities
and the ability to act as substrate for glycogen synthase. Forms
of recombinant GNN, truncated at their C-termini, were more
stable against proteolysis and were still active. We also demon-
strated that the full-length and truncated proteins could re-
store glycogen storage to a S. cerevisiae mutant strain
lacking both GLG1 and GLG2 genes.
In the present work, we have extended the functional char-
acterization of the GNN protein by identifying Tyr196 and
Tyr198 as the glucosylation sites and determining the contribu-
tion of each residue to the self-glucosylation activity. We also
analyzed the physical interactions between GNN and N. crassa
glycogen synthase (GSN) [14] by the yeast two-hybrid assay, to
identify the regions in glycogenin important for interaction
with glycogen synthase. Our results demonstrate that the C-
terminus of GNN is responsible for the interaction with glyco-
gen synthase, although the same region was not important for
functional activities, as previously demonstrated [13]. Further-
more, the glucosylation status of GNN seems not to interfere
with the interaction with glycogen synthase.Fig. 1. Kinetics of GNND306. (A) Time course of glycogenin self-
glucosylation reaction. Puriﬁed GST-GNND306 (0.8 lg) was incu-
bated with UDP-[14C]glucose at 30 C, as described in Section 2. At the
indicated times, aliquots were withdrawn and analyzed by SDS–PAGE
gel stained with Coomassie blue (lower panel) followed by autoradi-
ography (upper panel). (B) Km determination of glycogenin for the
substrate UDP-glucose. GST-GNND306 (0.8 lg) was allowed to self-
glucosylate in the presence of the indicated amounts of UDP-
[14C]glucose at 30 C for 20 min. After that, aliquots were removed
and spotted on P81 chromatography papers, washed in 0.5%
phosphoric acid and quantiﬁed by scintillation counting.2. Materials and methods
2.1. Yeast strains, plasmid constructions and site-directed mutagenesis
Saccharomyces cerevisiae strains EG328-1A (MATa trp1 leu2 ura3-
52) and CC9 (MATa trp1 leu2 ura3-52 glg1-2::LEU2 glg2::URA3)
were used in the complementation assays, and strain PJ69-4A [15]
was used in the two-hybrid assay. Plasmid pRS424-GPD [16] was used
for expression of the Glg1 and Glg2 proteins [7], and the GNND306,
GNND306Y196F and GNND306Y196/198F proteins [13] in yeast
cells. The plasmids were transformed into yeast cells by lithium acetate
method [17] and clones were selected by growth on synthetic medium
lacking tryptophan (SD-Trp). The plasmids pGBT9 and pGAD424
[18] were used for expression of the full-length and truncated forms
of GSN and GNN, respectively, in the yeast two-hybrid assay. Plasmid
pGEX-4T1 (Amersham Biosciences) was used for production of
GNND360 and GNND306 proteins in E. coli.
Two-step PCR [19] was used to mutate Tyr196 and Tyr198 to Phe in
GNND360 andGNND306. The plasmid pMOS-GNN (AmershamBio-
sciences) containing thewhole cDNAsequence encodingGNNwas used
in the ﬁrst PCR reaction. To make the Tyr196Phe mutation, two DNA
fragments were initially ampliﬁed by the primers T7 promoter (5 0-TAA-
TACGACTCACTATAGGG-3 0)/GNNY196F-R (5 0-GGCCGGGAT
GTACTGGAAGTGGGCGGAGGGCGT-3 0) and GNNY196F-F
(5 0-ACGCCCTCCGCCCACTTCCAGTACATCCCGGCC-3 0)/U18
(5 0-GTTTTCCCAGTCACGACG-3 0). For the double mutation,
Tyr196/198Phe, the two fragments were ampliﬁed by the primers
GNNY196/198F-F (5 0-CTCCGCCCACTTCCAGTTCATCCCGG-
3 0)/U18 and GNNY196/198F-R (5 0-CCGGGATGAACTGGAAGT
GGGCGGAG-3 0)/T7. The mutant nucleotides are underlined. The sec-
ond PCRused the primersGNN-EcoF (5 0-GAATTCATGGCGATCA
CCAAAGGA-3 0) andGNND3-R (5 0-TGGTGTAGGTGCTATGGG-
3 0), and the ampliﬁed products were digested with ClaI and SacII. The
resulting 400 bp fragments were ligated into pGEX-GNND360 and
pGEX-GNND306, previously digested with ClaI and SacII, generating
pGEX-GNND360Y196F, pGEX-GNND 360Y196/198F, pGEX-
GNND306Y196F and pGEX-GNND306Y196/198F plasmids.
2.2. Production, puriﬁcation and analysis of mutant GNN proteins
The GNN proteins were expressed in E. coli BL21(DE3) as GST-fu-
sion proteins in 500 ml LB medium. Cells were grown at 37 C to an
OD  0.7 and induced by addition of 0.1 mM ﬁnal concentration
IPTG for 3 h at 30 C. Cells were collected by centrifugation and re-
suspended in homogenizing buﬀer (1 · PBS, 1 mM PMSF, 1 mM ben-zamidine, 5 mM DTT, 0.1 mM TLCK, 1 lg/ml pepstatin and aproti-
nin). Cells were broken by two passages through a French Pressure
cell at 18 000 psi. The supernatant was clariﬁed by centrifugation at
18 000 rpm for 20 min and subjected to aﬃnity chromatography on
a GSTrap column (1 ml) in an A¨kta Prime Protein Puriﬁcation System
(Amersham Biosciences). The recombinant proteins were eluted with
10 mM reduced glutathione and dialyzed against 1 l of homogenizing
buﬀer. The self-glucosylation reaction was carried out using 0.8 lg of
protein in 50 mM HEPES, pH 7.6, 5 mM MnSO4, 2 mM DTT, and
19 lM UDP-[U 014C]glucose (263 mCi/mmol) at 30 C. An aliquot
(3 ll) was removed from the reaction, spotted onto 2 · 2 cm square
P81 chromatography paper and submitted to three washes (30 min
each) in 0.5% phosphoric acid and once in ethanol. The papers were
dried and counted in a liquid scintillation counter. The remaining reac-
tion was stopped by addition of 4· SDS–PAGE sample buﬀer, boiled
and subjected to SDS–PAGE. The gel was stained, destained, rinsed in
water and then in Fluoro-Hance. The gel was dried and autoradio-
graphed.
The proteins (GNND306, GNND306Y196F, and GNND306Y196/
198F) were also analyzed by their ability to complement the glg1
and glg2 mutations in S. cerevisiae strain CC9. Expression of either
GLG1 or GLG2 genes was used as a positive control and complemen-
tation was followed by analysis of glycogen content. Qualitative glyco-
gen measurement was performed by spotting 5 ll of a stationary phase
culture on SD-Trp plates. Patches were grown for 2 days at 30 C and
then inverted over iodine crystals for detection of glycogen accumula-
tion. Quantitative glycogen measurement was performed as described
by Hardy and Roach [20].
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Recombinant GNND360 protein was produced in E. coli fused to
GST and puriﬁed by aﬃnity chromatography. Puriﬁed GST-
GNND360 was allowed to self-glucosylate [13] and was then subjected
to SDS–PAGE. The corresponding band was excised from the gel and
subjected to in-gel trypsin digestion. The resulting peptides were recov-
ered from the gel slices and analyzed by mass spectrometry at the Pro-
teomics Core Facility, Indiana University School of Medicine,
Indianapolis, IN. Brieﬂy, initial characterization of tryptic peptides
was carried out by matrix-assisted laser desorption ionization-time of
ﬂight mass spectrometry (MALDI-TOF), using a Micromass M @
LDI-TOF instrument operating in the positive reﬂectron mode. Fur-
ther analysis, and characterization of the glucosylated peptide was
achieved using a capillary liquid chromatography system, coupled with
a quadruple time of ﬂight (Q-TOF) mass spectrometer (Micromass) ﬁt-
ted with a Z-spray ion source. Separation of the peptides was carried
out on a reverse-phase capillary column running at 300 nl/min. The
mobile phase consisted of a linear gradient from 100% solution A
(0.1% formic acid/3% acetonitrile, v/v, in water) to 70% solution B
(0.1% formic acid/97% acetonitrile, v/v, in water) for 50 min followed
by a 10-min gradient to 100% solution B. Mass spectra were acquired
in positive ion mode.
2.4. GSN and GNN plasmid constructions for two-hybrid assays
The entire coding sequence of gnn cDNA [13] was ampliﬁed and in-
serted into pGAD424 vector leading to the pGAD424-GNN plasmid.
The truncated GNN proteins GNND613, GNND545, GNND360,
GNND306, and GNND245 were prepared by amplifying the DNA
fragments with the sense primer GNN-EcoF (sequence above) and
antisense primers containing stop codon at internal positions of the
cDNA, and then, insertion of the fragments into pGAD424 plasmid.
The pGAD424-GNN490-664 and pGAD424-GNN337-664 plasmids
were constructed by ampliﬁcation of the sequences using internal prim-
ers in the gnn cDNA sequence and the antisense primer NcGN-3R
(sequence above). EcoRI/SacII DNA cassettes from pGEX-
GNND360Y196F and pGEX-GNND360Y196/198F were exchanged
into pGAD424-GNN to generate the pGAD424-GNNY196F and
pGAD424-GNNY196/198F plasmids, respectively. EcoRI/SalI DNA
cassettes from pGEX-GNND360Y196F and pGEX-GNND360Y196/
198F were exchanged into pGAD424-GNND306 to construct the
pGAD424-GNND306Y196F and pGAD424-GNND306Y196/198FFig. 2. Analysis of glycogenin glucosylation by mass spectrometry. The peptid
analyzed by MALDI-TOF. The ion spectrum is shown in the mass range 3000
additional glucose units added to the unmodiﬁed peptide (mass 3013.38).plasmids, respectively. The pGBT9-GSN plasmid resulted from
insertion of the entire ORF of the gsn cDNA, ampliﬁed with the oligo-
nucleotides GSNth-F (5 0-GAATTCATGGCCCACGACAACCGTG-
3 0)/GSNth-R (5 0-CTGCAGTTACCTGGTGCCGTTG-3 0) [14], into
pGBT9 vector. cDNAs encoding the truncated GSN proteins
GSND387 and GSND624 were constructed by PCR ampliﬁcation
using the oligonucleotide GSNth-F and antisense oligonucleotides
containing stop codon, and inserting the fragments into pGBT9 plas-
mid. Sense oligonucleotides hybridizing at internal sequences of the gsn
cDNA and the antisense oligonucleotide GSNth-R were used to ampli-
fy DNA fragments encoding the proteins GSN150-706 and GSN347-
706, and insertion of the DNA fragments into pGBT9 vector.
2.5. Yeast two-hybrid assay
To analyze the interactions between GSN and GNN proteins,
pGBT9-GSN plasmid was co-transformed with the diﬀerent
pGAD424-GNN constructs in the yeast strain PJ69-4A. In the same
way, pGAD424-GNN plasmid was co-transformed with the various
pGBT9-GSN constructs. The transformants were selected by plating
on the selective medium SC-Trp-Leu and after on SC-Trp-Leu-
His + 5 mM 3 aminotriazole (3-AT) plates (2% glucose, 0.67% yeast
nitrogen base without amino acids and 0.15% amino acid mixture).
The presence of all proteins was conﬁrmed by Western blot analysis
using either anti-GSN or anti-GNN antibodies. Quantitative analysis
was performed by liquid b-galactosidase assay [21] from cells collected
after 24 h of growth in liquid cultures.3. Results and discussion
3.1. Kinetics of GNN
In previous work, we described the isolation of the N. cras-
sa gnn cDNA and demonstrated that the protein (GNN) had
several properties associated with glycogenins [13]. The re-
combinant GNN was very susceptible to proteolysis toward
the C-terminus, resulting in smaller polypeptides that none-
theless retained most enzymatic activity. Since GNN is one
of the largest glycogenin-like proteins isolated so far, wees generated by trypsin digestion of glucosylated GST-GNND360 were
–4000. The peak masses are shown along the spectrum and refer to the
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tant for the glycogenin activities. To investigate this hypoth-
esis, we extended the biochemical analysis of GNN. Initially,
we determined the kinetic properties of GNN by using a
truncated protein, which lacks 358 amino acid residues from
the C-terminal region (GNND306). We elected to use the
truncated protein because expression of the full-length pro-
tein results in a heterogeneous mixture due to C-terminal
proteolysis [13]. This protein was produced in E. coli as a
GST-tagged protein. Fig. 1A shows the time course of the
self-glucosylation reaction when the recombinant protein
was incubated in the presence of UDP-[U-14C]glucose and
subsequently analyzed by SDS–PAGE. The reaction pro-
gressed linearly up to 20 min and then reached a plateau at
which no further incorporation occurred. A slight reduction
in mobility was observed as a function of the incorporation
of glucose residues. The recombinant protein self-glucosy-
lated with a Km toward the substrate UDP-glucose of about
4.41 lM (Fig. 1B). The kinetic data on the self-glucosylation
activity of GNN are in agreement with data described for
mammalian [6,22,12] and yeast [7] glycogenins. The Km value
is low, similar to the rabbit protein (4.5 lM), and the self-
glucosylation reaction is activated by Mn2+ ions.Fig. 3. Self-glucosylation of WT and mutant glycogenins. WT proteins
(GNND360 and GNND306) and mutant proteins (GNND360Y196F,
GNND360Y196/198F, GNND306Y196F and GNND306Y196/198F)
were analysed by the ability to self-glucosylate. The proteins
(0.8 lg) were incubated with UDP-[14C]glucose at 30 C for 20 min.
Aliquots were removed and spotted in P81 papers and counted by
liquid scintillation (C). The remaining reaction was stopped by adding
sample buﬀer (4X) and boiling. Samples were analyzed by SDS–PAGE
gel stained with Coomassie blue (lower panels), followed by autora-
diography (upper panels). (A) Self-glucosylation of GNND360
(1), GNND360Y196F (2) and GNND360Y196/198F (3) proteins,
(B) Self-glucosylation of GNND306 (4), GNND306Y196F (5) and
GNND306Y196/198F (6) proteins.3.2. Analysis of GNN self-glucosylation site
To identify the acceptor site of glucose in the self-glucosyla-
tion reaction, we used the GNND360 protein fused to GST.
The full-length protein is so susceptible to proteolysis when
produced in E. coli that it is impossible to produce more than
a complex mixture of proteolytically related species. Therefore,
we used a truncated form of GNN (GNND360), which lacks
304 amino acids from the C-terminal region and which we
know to be catalytically active [13]. This form still undergoes
some proteolysis to generate another species but this did not
interfere with the analysis. The GST-GNND360 was allowed
to self-glucosylate and the band corresponding to the non-pro-
teolysed protein was excised from the SDS–PAGE gel, and
analyzed by mass spectroscopy after trypsin digestion. A pep-
tide corresponding to amino acid residues 179–203
(NTYNRLSFTYNVTPSAHYQYIPAYK) was identiﬁed in
GNN to be modiﬁed by addition of glucose residues. This pep-
tide still contains an arginine residue (Arg183) that is, most
likely, a missed site for trypsin cleavage. This peptide contains
the Tyr196 residue that aligns with Tyr194 and Tyr232, which
were demonstrated to be the glucosylation sites in the rabbit
skeletal muscle glycogenin [6], and in the yeast Glg2p [7] pro-
teins, respectively. The mass spectrum (Fig. 2) indicated the
presence of a peak corresponding to the parent peptide
(3013.38 atomic mass observed) and seven additional ions of
higher mass. The peaks represented a successive increase of 162
mass units, which corresponds to the mass diﬀerence of one
additional glucose residue. The signal corresponding to +7 glu-
coses is considerably weaker and the most prominent peak cor-
responded to the parent peptide plus two glucose residues.
Sequencing of the peptide showed that the Tyr196 residue
was the primary modiﬁed residue (not shown).3.3. Analysis of mutant GNN proteins
Site-directed mutagenesis was used to generate GST-
GNND360 and GST-GNND306 proteins with Tyr196 mutated
to Phe. Assays of self-glucosylation of the two mutant formsrevealed a residual incorporation of 14C-radiolabelled glucose
in the GST-GNND360Y196F protein (Fig. 3A, lane 2) not
present in the GST-GNND306Y196F protein (Fig. 3B, lane
5). This result suggested the existence of another residue that
could be a secondary glucosylation site in GNN. Thus, the
double mutant GST-GNND360Y196/198F and GST-
GNND306Y196/198F proteins were generated by site-directed
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served in the GST-GNND360Y196F mutant was abolished
in the double mutant GST-GNND360Y196/198F (Fig. 3A,
lane 3). Consistent with this result, no incorporation was seen
in the double mutant GST-GNND306Y196/198F (Fig. 3B,
lane 6). Quantitative analysis of incorporation revealed that
the rate of self-glucosylation of the GST-GNND360 and
GST-GNND306 proteins were approximately 16.81 and
9.95 nmol/min/mg, respectively, while in the mutant GST-
GNND360Y196F this value was approximately 1.42 nmol/
min/mg (Fig. 3C). Double mutants containing Tyr196Phe
and Tyr202Phe mutations were also generated but the results
indicated no glucosylation at Tyr202 (data not shown). In
summary, the data suggest that GNN contains two glucosyla-
tion sites, Tyr196 and Tyr198. The yeast Glg2p isoform has
two glucosylation sites (Tyr230 and Tyr232), which are very
close together, but in this protein both sites contributed
equally to the self-glucosylation [7]. A recent study [23] has
shown that in bacterially produced Glg2p, both Tyr residues
can be modiﬁed simultaneously in the same Glg2p monomer.
The relevance of two glucosylation sites was also analyzed in
vivo, by expression of the mutant forms of GNND306 in a
yeast strain (CC9) lacking both glycogenin genes (glg1 glg2).
Fig. 4 shows the glycogen accumulation in cells complementedFig. 4. Functional complementation of S. cerevisiae glycogenin
mutant strain by N. crassa glycogenin. GNND306 and mutant proteins
GNND306Y196F and GNND306Y196/198F were expressed in glg1
glg2 yeast cells (CC9) from high copy number vector pRS424 under the
control of the GAPD promoter. Samples 1 and 2, WT and CC9
strains, respectively, harboring pRS424; samples 3 and 4, CC9 cells
overexpressing Glg1p and Glg2p, respectively; samples 5, 6, and 7,
CC9 cells overexpressing GNND306, GNND306Y196F and
GNND306Y196/198F, respectively. (A) Iodine staining of colonies
grown on SD-Trp plate for 2 days at 30 C. (B) Glycogen content.
Glycogen was determined enzymatically as described in Section 2.with GNND306 and the mutant proteins GNND306Y196F
and GNND306Y196/198F (Fig. 4A). Expression of the trun-
cated protein GNND306 was able to restore the glycogen levels
close to the physiological levels when compared with both the
WT cells or CC9 cells expressing either GLG1 or GLG2 genes.
Expression of the single mutant GNND306Y196F correlated
with a reduced but substantial glycogen accumulation, corre-
sponding to 30% of the glycogen content observed in the cells
complemented with the WT GNN (Fig. 4B, sample 6). More-
over, glycogen was not accumulated when the double mutant
protein GNND306Y196/198F was expressed in the mutant
yeast cells (Fig. 4B, sample 7). The contribution of the
Tyr198 residue in the self-glucosylation reaction was more evi-
dent when in vivo analysis was performed. This result conﬁrms
both Tyr196 and Tyr198 residues in GNN protein as the phys-
iological relevant glucosylation sites, although Tyr196 is the
most important site.
3.4. Physical interactions between glycogenin and glycogen
synthase
We undertook a systematic truncation mutagenesis protocol
to map the regions that might be important for physical inter-
action between glycogenin (GNN) and glycogen synthase
(GSN). Little information concerning this issue is available
from studies on yeast proteins [7]. For this purpose, we gener-
ated deletions in both proteins and used the yeast two-hybrid
assay to evaluate the possible domains involved in the
GNN–GSN interaction. Fig. 5A shows a schematic represen-
tation of the truncated forms that were assayed. Western blot
with anti-GSN and anti-GNN antibodies conﬁrmed the pres-
ence of proteins. In one set of assays, GSN protein was used
as bait with a series of truncated GNN proteins as prey, and
the interactions were evaluated by quantifying the b-galactosi-
dase activity (Fig. 5B). Entire GNN and GSN proteins inter-
acted strongly to each other, as expected. Deletion of the 51
(GNND613) and 119 (GNND545) C-terminal amino acids re-
duced the interaction between the two proteins to about 82%
and 69%, respectively. Moreover, the truncated mutants
GNND360, GNND306, and GNND245 interacted much more
weakly with GSN, yielding only about 10% of the reporter
activity detected with wild type GNN. On the other hand, a
polypeptide comprising only the C-terminus of GNN
(GNN490–664), interacted poorly with GSN and this was only
slightly enhanced by enlarging it to span residues 337–664
(GNN337–664). Taken together, these results argue that the
C-terminal region of GNN, starting at residue 360, dominates
the interaction with GSN but that interaction depends on the
integrity of the N-terminus. Finally, the interaction between
the two proteins was barely aﬀected by mutations in one or
both glucosylation sites, demonstrating that the glucosylation
status of glycogenin must not be important in the interaction
with GSN. Cheng et al. [7] have proposed that the extreme
C-terminus domain in Glg2p was required for interaction with
Gsy2p since this fragment was isolated in a two-hybrid screen-
ing using Gsy2p as bait. The C-terminal domain in GNN
shares very low homology to Glg2p and may function some-
what diﬀerently.
In another set of experiments, GNN was used as bait and
four deletions in GSN were assayed. The N- and C-terminal
regions of GSN (GSND387 and GSN347–706) were individu-
ally assayed and neither allowed signiﬁcant interaction with
GNN. Extension of the C-terminus in GSN150–706 did not
Fig. 5. Two-hybrid assay of GNN and GSN interactions. Plasmid constructions were described in Section 2. (A) A schematic representation of the
plasmid constructions is shown. (B) Interaction analysis was measured by liquid b-galactosidase of yeast crude extracts expressing the indicated
proteins. The results are the average of three independent experiments.
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30% of wild type if the C-terminal truncation was reduced
to 82 residues. In general, the N- and C-terminus of glycogen
synthases contain the regulatory sites for reversible phosphor-
ylation. This set of results suggests that much of the sequenceof the GSN protein is needed for interaction with GNN
although the extreme C-terminus may be especially impor-
tant.
One might question whether the weak, residual interaction
between GSN and GNN truncated at C-terminus might be
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saccharide chain of glycogenin. Even though the interactions
take place in the nucleus in the two-hybrid analysis GNN must
be translated in the cytosol, and will likely be glucosylated and
translocated to the nucleus carrying an oligosaccharide chain
attached. In fact, the extension of the oligosaccharide chain
has been proposed to play a role in the ability of glycogen syn-
thase to elongate self-glucosylated glycogenin in mammals
[24]. However, our results using single or double mutant pro-
teins argue that GNN–GSN interaction does not depend on
the glucosylation status of glycogenin. In this case, other pro-
tein–protein determinants may explain the capacity of those
two proteins to interact, albeit not strongly. Recent reports
describing the existence of a protein called GNIP [25], which
interacts with mammalian glycogenin, suggest that multimeric
complexes may involve glycogenin and glycogen synthase [26].
Although no GNIP counterpart has been identiﬁed in microor-
ganisms, we cannot exclude the possibility that other proteins
may exist, and to be implicated on the physical interactions
and activity of both glycogenin and glycogen synthase.
Acknowledgements: The authors acknowledge FAPESP (Fundac¸a˜o de
Amparo a` Pesquisa do Estado de Sa˜o Paulo) for the fellowship to R.
M. de Paula and for the ﬁnancial support to M. C. Bertolini, and
CNPq (Conselho Nacional de Desenvolvimento Cientı´ﬁco e Tecnolo´g-
ico). Part of this work was supported by National Institutes of Health
Grant DK42576 (to P.J. Roach). We acknowledge Dr. E. Hilario for
the ﬁnal work on the ﬁgures.References
[1] Alonso, M.D., Lomako, J., Lomako, W.M. and Whelan, W.J.
(1995) A new look at the biogenesis of glycogen. FASEB J. 9,
1126–1137.
[2] Rodriguez, I.R. and Whelan, W.J. (1985) A novel glycosyl-amino
acid linkage: rabbit muscle glycogen is covalently linked to a
protein via tyrosine. Biochem. Biophys. Res. Commun. 132, 829–
836.
[3] Smythe, C. and Cohen, P. (1991) The discovery of glycogenin and
the priming mechanism for glycogen biogenesis. Eur. J. Biochem.
200, 625–631.
[4] Lomako, J., Lomako, W.M. and Whelan, W.J. (1988) A self-
glucosylating protein is the primer for rabbit muscle glycogen
biosynthesis. FASEB J. 2, 3097–3103.
[5] Caudwell, F.B. and Cohen, P. (1980) Puriﬁcation and subunit
structure of glycogen-branching enzyme from rabbit skeletal
muscle. Eur. J. Biochem. 109, 391–394.
[6] Cao, Y., Mahrenholz, A.M., DePaoli-Roach, A.A. and Roach,
P.J. (1993) Characterization of rabbit skeletal muscle glycogenin.
Tyrosine 194 is essential for function. J. Biol. Chem. 268, 14687–
14693.
[7] Cheng, C., Mu, J., Farkas, I., Huang, D., Goebl, M.G. and
Roach, P.J. (1995) Requirement of the self-glucosylating initiator
proteins Glg1p and Glg2p for glycogen accumulation in Saccha-
romyces cerevisiae. Mol. Cell. Biol. 15, 6632–6640.
[8] Mu, J., Cheng, C. and Roach, P.J. (1996) Initiation of glycogen
synthesis in yeast. Requirement of multiple tyrosine residues forfunction of the self-glucosylating Glg proteins in vivo. J. Biol.
Chem. 271, 26554–26560.
[9] Gibbons, B.J., Roach, P.J. and Hurley, T.D. (2002) Crystal
structure of the autocatalytic initiator of glycogen biosynthesis,
glycogenin. J. Mol. Biol. 319, 463–477.
[10] Smythe, C., Watt, P. and Cohen, P. (1990) Further studies on the
role of glycogenin in glycogen biosynthesis. Eur. J. Biochem. 189,
199–204.
[11] Cao, Y., Steinrauf, L.K. and Roach, P.J. (1995) Mechanism of
glycogenin self-glucosylation. Arch. Biochem. Biophys. 319, 293–
298.
[12] Alonso, M.D., Lomako, J., Lomako, W.M. and Whelan, W.J.
(1995) Catalytic activities of glycogenin additional to autocata-
lytic self-glucosylation. J. Biol. Chem. 270, 15315–15319.
[13] de Paula, R.M., Wilson, W.A., Terenzi, H.F., Roach, P.J. and
Bertolini, M.C. (2005) GNN is a self-glucosylating protein
involved in the initiation step of glycogen biosynthesis in
Neurospora crassa. Arch. Biochem. Biophys. 435, 112–124.
[14] de Paula, R.;, Azzariti de Pinho, C.;, Terenzi, H.F. and Bertolini,
M.C. (2002) Molecular and biochemical characterization of the
Neurospora crassa glycogen synthase encoded by the gsn cDNA.
Mol. Genet. Genomics 267, 241–253.
[15] James, P., Halladay, J. and Craig, E.A. (1996) Genomic libraries
and a host strain designed for highly eﬃcient two-hybrid selection
in yeast. Genetics 144, 1425–1436.
[16] Mumberg, D., Muller, R. and Funk, M. (1995) Yeast vectors for
the controlled expression of heterologous proteins in diﬀerent
genetic backgrounds. Gene 156, 119–122.
[17] Schiestl, R.H. and Gietz, R.D. (1989) High eﬃciency transfor-
mation of intact yeast cells using single stranded nucleic acids as a
carrier. Curr. Genet. 16, 339–346.
[18] Chien, C.T., Bartel, P.L., Sternglanz, R. and Fields, S. (1991) The
two-hybrid system: a method to identify and clone genes for
proteins that interact with a protein of interest. Proc. Natl. Acad.
Sci. USA. 88, 9578–9582.
[19] Ausubel, F., Brent, R., Kingston, R.E., Moore, D.D., Seidman,
J.G., Smith, J.A. and Struhl, G. (1996) Current Protocols in
Molecular Biology, John Wiley and Sons, Inc., New York.
[20] Hardy, T.A. and Roach, P.J. (1993) Control of yeast glycogen
synthase-2 by COOH-terminal phosphorylation. J. Biol. Chem.
268, 23799–23805.
[21] Rose, M. and Botstein, D. (1983) Construction and use of gene
fusions to lacZ (beta-galactosidase) that are expressed in yeast.
Methods Enzymol. 101, 167–180.
[22] Pitcher, J., Smythe, C. and Cohen, P. (1988) Glycogenin is the
priming glucosyltransferase required for the initiation of glycogen
biogenesis in rabbit skeletal muscle. Eur. J. Biochem. 176, 391–
395.
[23] Albrecht, T., Haebel, S., Koch, A., Krause, U., Eckermann, N.
and Steup, M. (2004) Yeast glycogenin (Glg2p) produced in
Escherichia coli is simultaneously glucosylated at two vicinal
tyrosine residues but results in a reduced bacterial glycogen
accumulation. Eur. J. Biochem. 271, 3978–3989.
[24] Cao, Y., Skurat, A.V., DePaoli-Roach, A.A. and Roach, P.J.
(1993) Initiation of glycogen synthesis. J. Biol. Chem. 268, 21717–
27121.
[25] Skurat, A.V., Dietrich, A.D., Zhai, L. and Roach, P.J. (2002)
GNIP, a novel protein that binds and activates glycogenin, the
self-glucosylating initiator of glycogen biosynthesis. J. Biol.
Chem. 277, 19331–19338.
[26] Zhai, L., Dietrich, A.D., Skurat, A.V. and Roach, P.J. (2004)
Structure–function analysis of GNIP, the glycogenin-interacting
protein. Arch. Biochem. Biophys. 421, 236–242.
